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Abstract: This study focused on the effects of zinc oxide nanoparticles (nano-ZnO) on spatial 
learning and memory and synaptic plasticity in the hippocampus of young rats, and tried to 
interpret the underlying mechanism. Rats were randomly divided into four groups. Nano-ZnO 
and phosphate-buffered saline were administered in 4-week-old rats for 8 weeks. Subsequently, 
performance in Morris water maze (MWM) was determined, and then long-term potentiation 
(LTP) and depotentiation were measured in the perforant pathway to dentate gyrus (DG) in 
anesthetized rats. The data showed that, (1) in MWM, the escape latency was prolonged in the 
nano-ZnO group and, (2) LTP was significantly enhanced in the nano-ZnO group, while depo-
tentiation was barely influenced in the DG region of the nano-ZnO group. This bidirectional 
effect on long-term synaptic plasticity broke the balance between stability and flexibility of 
cognition. The spatial learning and memory ability was attenuated by the alteration of synaptic 
plasticity in nano-ZnO-treated rats. 
Keywords: zinc oxide nanoparticles, synaptic plasticity, long-term potentiation, depotentiation, 
spatial learning, memory
Introduction
Zinc oxide nanoparticles (nano-ZnO) are now widely applied in many products such 
as toothpaste, beauty agents, sunscreens, textiles, wall paints, and other building 
materials. Many properties of nanoparticles, such as surface and interface effects,1 
quantum size effect,2 photocatalytic properties,3 and phonon properties,4 have been 
investigated. In humans, environmental exposure to nano-ZnO has shown that it stayed 
in the stratum corneum and accumulated in skin folds and/or hair follicle roots of 
the skin.5 Also, exposure to low concentrations of nano-ZnO indicates a genotoxic 
potential mediated by lipid peroxidation and oxidative stress in epidermal cells.6 
  Similarly, the liver, spleen, heart, pancreas, and bone were the target organs for 20- and 
120-nm ZnO exposure.7 However, nano-ZnO was selectively toxic toward potential 
disease-causing cells, and has been regarded as a possible treatment for cancer and/
or autoimmune diseases.8
With regard to nervous tissue, data have shown that Neuro-2A cells exposed to 
nano-ZnO at doses . 100 µg/mL in vitro become abnormal in size, and display cel-
lular shrinkage and detachment from the surface of flasks. Flow cytometer tests show 
that apoptosis occurs in mammalian neuro-2A cells when exposed to nano-ZnO.9 
Human neural cells and fibroblasts undergo apoptosis and necrosis10 when exposed 
to nano-ZnO. Recent experimental studies of acutely isolated rat hippocampal CA3 
pyramidal neurons show that exposure to nano-ZnO results in increases in amplitude International Journal of Nanomedicine 2011:6
100 nm
Figure 1 Transmission electron microscopy image of nanoscaled ZnO particles.
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of sodium current (INa), delayed rectifier potassium current 
(IK), and excitability of neurons. The results suggest that 
these mechanisms may contribute to cell apoptosis.11,12 
Nano-ZnO increases neuronal excitability by enhancement 
of Na+ influx leading to the accumulation of intracellular 
Ca2+. Furthermore, concentration of intracellular Ca2+ is a 
crucial and essential source of long-term potentiation (LTP) 
and long-term depotentiation (LTD) in both inducing and 
maintaining phases.8 Such effects manifest dose dependency 
but no size-dependent toxicity.13
Although recent epidemiological studies demonstrated 
a correlation between exposure to fine particulate matter in 
industrial applications and an increased incidence of morbid-
ity, the mechanisms behind this correlation remain largely 
unknown. Indeed, few studies of nano-ZnO properties have 
been concerned with actions in the nervous system and 
effects on cognition. Given that nano-ZnO is widely used in 
fields which are closely related to the human living environ-
ment, whether long exposure to nanoparticles could have a 
damaging impact on cognitive function is unclear. Therefore, 
based on the need for biological safety, this study focused 
on the effects of nano-ZnO on spatial learning and memory 
and synaptic plasticity in the hippocampus of the immature 
nervous system in Wistar rats, and attempted to interpret the 
underlying mechanism.
Materials and methods
Animals and treatment
Wistar rats (postnatal days 28) were placed under envi-
ronmentally controlled conditions (0700–1900 hours 
light/dark cycle; 20°C–24°C) and permitted free access 
to food and water throughout the experiment. The proce-
dures involving the animals and their care complied with 
national and international rules and policies. Experiments 
were designed to minimize the number of animals used 
and their suffering.
A total of 32 rats was randomly divided into four groups: 
(1) nano-ZnO-treated group for Morris water maze (MWM) 
test (n = 8), (2) nano-ZnO-treated group for electrophysiolog-
ical experiment (n = 8), (3) normal control group for MWM 
(n = 8), (4) normal control group for electrophysiological 
experiment (n = 8). Rats were intraperitoneally injected 
with nano-ZnO (4 mg/kg, 4 mg/mL, biweekly [biw])14 and the 
same volume of phosphate-buffered saline (PBS) (biw) from 
the fourth to the twelfth week after birth, respectively.
In the present study, intraperitoneal administration 
instead of intracerebral or intraventricular injection 
was applied as delivery pathway. The main reason was 
to avoid the damage of surgical operation. Whether 
nano-ZnO can cross the blood–brain barrier (BBB) has 
not been determined. However, other studies on the 
effects of nanoparticles, have reported that other kinds of 
nanoparticles (like gold nanoparticles) injected into the tail 
vein of healthy mice show a biodistribution in the brain, 
and this has been characterized in detail.15 One other study 
exposing rats to ZnO given daily (100 mg) via a gastric 
tube, showed morphological and histochemical changes in 
the brains of rats.16 Based on these data, we assumed that 
nano-ZnO given intraperitoneally can cross the BBB and 
have influence on the brain.
Nano-ZnO and suspension preparation
In this research, the nano-ZnO was analyzed and provided 
by the Research Institute of Science and Technology (RSTI) 
University of Hertfordshire, Hampshire, UK. The morphol-
ogy of the nano-ZnO was investigated through transmission 
electron microscopy (TEM) (Tecnai G2 20S-TWIN, FEI 
Co, Portland, OR). The TEM images showed that nano-ZnO 
were within the sizes 20–80 nm (as shown in Figure 1). 
Suspension of nano-ZnO was prepared in PBS (1 mg nano-
ZnO in 1 mL PBS) at 25°C. Because nano-ZnO was barely 
dissolved in water, ultrasound was applied for 1 hour at 
a power of 3 W to ensure nanoparticle dispersion and to 
prevent nano-ZnO deagglomeration and   reagglomeration.17 
The resulting suspension was then immediately pipetted 
into a glass container and administrated intraperitoneally 
to the rats.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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MWM
After 8-week intraperitoneal administration, MWM was 
performed. MWM is an established test of spatial learning 
and of reference memory.18 The maze was placed in a room 
with soft lighting. All light fixtures in the room were covered 
with white sheets to reduce the brightness of the lights and 
eliminate their reflection in the water. All experiments were 
performed at 0800 and 1800 hours. The MWM was made of 
a circular tub (height 60 cm, diameter 150 cm), and the water 
was heated to 23.5°C using a built-in heater. The pool was 
divided into four quadrants: northeast (NE), northwest (NW), 
southeast (SE), and southwest (SW). A circular platform 
(diameter 10 cm) was placed 1.5 cm below the surface of 
the water in the middle of the NE quadrant of the pool, and 
visual cues were placed on the walls surrounding the pool. 
Rats had to find the location of the hidden platform to escape 
from the water.19,20 Rats received two trials a day from four 
start positions with a 5-minute intertrial interval during which 
animals rested in their home cage. Rats were put in the pool 
facing the sidewall and were allowed 60 seconds to locate 
the platform. Rats that failed to locate the platform within 
60 seconds were guided by hand to the platform. All rats were 
allowed to sit on the platform for 10 seconds before being 
removed from the pool.21 During the first 5 days of training 
(acquisition phase), the hidden platform was consistently 
located in the NE quadrant.
On day 6 (retention phase), a probe trial was carried 
out. The probe trial was a 60-second test, but there was no 
platform in the pool. The time that each rat spent in each 
quadrant in which the platform had been located during 
training was recorded.
On days 7 and 8 (reacquisition phase), reverse platform 
training was instituted, and for this, the hidden platform was 
moved from the NE quadrant to the center of the SW quad-
rant (25 cm from the pool wall) without changing any distal 
visual cues. Reversal trials were administered as described 
in the acquisition phase, except that the platform was moved 
to the middle of the SW (opposite) quadrant.
Data were collected with a TopScan (Clever Sys Inc, 
Reston, VA) system, which records MWM performance 
automatically using a digital video camera mounted directly 
above the pool. Data were then automatically scored via the 
TopScan computer software package.
LTP and depotentiation recording
On day 9, the rats were anesthetized with urethane (1.2 g/kg, 
intraperitoneally) and mounted on a stereotaxic frame (SR-6N; 
Narishige, Japan). Small holes were drilled in the skull to 
allow insertion of electrodes into the brain. The   stereotaxic 
coordinates were derived from Paxinos and   Watson.22 
A concentric bipolar stainless steel stimulating electrode with 
a tip separation of 0.5 mm was placed into the perforant path-
way (PP) (coordinates: 8.0 mm posterior to bregma, 4.4 mm 
lateral to the midline, 2.8–3.8 mm ventral from the cortical 
surface). A monopolar extracellular stainless steel recording 
electrode, 0.5 mm in diameter, was lowered into the dentate 
gyrus (DG) region (coordinates: 4.2 mm anterior to bregma, 
2.5 mm lateral to the midline, 3.0–3.7 mm ventral from the 
cortical surface).
After positioning the electrodes, the rats were left for 
a minimum period of 30 minutes for stability of baseline 
  recordings before starting the experiment. Evoked field 
responses were recorded (Neurolog NL 104, NL 125, 
PowerLab/8S; AD Instruments, Sydney, Australia). The 
slopes of field excitatory postsynaptic potential (fEPSP) were 
measured as the maximal slope between the 20%–80% points 
obtained on the first positive deflection of the potential.
For induction of LTP in the DG by stimulation of the 
PP, a probe stimulus was chosen at an intensity sufficient to 
produce a field response approximately 50% of spike thresh-
old (ST). Baseline responses (1 per minute) were recorded 
for 20 minutes followed by induced theta burst stimulation 
(TBS), consisting of four theta epochs delivered at 0.1 Hz. 
Each epoch consisted of 20 trains of 4 pulses (at 200 Hz) 
delivered at 5 Hz at the same stimulus intensity as the 
baseline pulse.23 High-frequency stimulation (HFS) lasted 
40 seconds in total. Following HFS, single-pulse recording 
resumed for 90 minutes.24
After LTP was recorded, the evoked responses of the last 
20 minutes were normalized and used for the baseline of depo-
tentiation (1 per minute), and then low frequency stimulation 
(LFS) containing two series of low-frequency stimulations 
(1 Hz, 10 minutes, total LFS 20 minutes) was applied. Fol-
lowing LFS, single-pulse recording resumed for 90 minutes. 
All operations were performed in the same time period.
statistical analysis
All data were analyzed using version 16 of the Statistical 
Package for Social Sciences (SPSS) (IBM, Somers, NY).
The baseline fEPSP (excitatory postsynaptic potential) 
data were obtained by averaging the response of stimulating 
PP, and analyzed offline with ES500 Scope and Chart Soft-
ware (eDaq, Sydney, Australia). Statistical significance was 
estimated using analysis of variance (ANOVA) with repeated 
measures. The probability level interpreted as statistically 
significant was P , 0.05.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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The data in each trial of MWM were combined to 
  calculate the mean for each training session. Data from 
the acquisition phase were analyzed by repeated-measures 
ANOVA (group/day) and one-way ANOVA, data from the 
retention phase were analyzed by one-way ANOVA,25 and 
data from the reacquisition phase were analyzed by repeated-
measures ANOVA (group/day) and one-way ANOVA. Results 
were expressed as the mean ± standard error of the mean. 
The probability level interpreted as statistically   significant 
was P , 0.05.
Results
Morris water maze
Spatial cognition capability was evaluated in rats using the 
MWM test.
Acquisition performance
The learning curves for MWM are shown in Figure 2. All 
rats showed a progressive improvement in the escape latency 
over time in a trial-dependent manner. This suggested that 
substantial learning had occurred in this period in both nano-
ZnO and control groups. During the first two trials of training, 
no significant differences were observed between the nano-
ZnO and control groups (trial 1, 69.17 ± 9.55 seconds and 
48.88 ± 9.83 seconds; trial 2, 28.25 ± 4.14 seconds and 21.25 ± 
5.71 seconds, P . 0.05). Conversely, the escape latencies were 
significantly higher in rats of the nano-ZnO-treated group than 
that of control group from the third to tenth trials (P , 0.05, 
P , 0.01). In the acquisition phase, statistical significances 
were observed between the nano-ZnO and control groups 
(P , 0.01, repeated-measures ANOVA, Figure 2A).
The same tendency was revealed in the data of the per-
centage of escape latency of temporal distribution in the 
target quadrant before the probe trial. Each performance of 
a trial was much worse in the nano-ZnO-treated group than 
that of control (P , 0.05, P , 0.01, Figure 2B). These data 
indicate that the learning performance of the nano-ZnO-
treated group was weakened by nano-ZnO compared with 
that of the control group.
retention performance
On day 6, rats of the nano-ZnO-treated group spent signifi-
cantly shorter times in the SW target quadrant than those of the 
control group (control, 55.81% ± 3.05%; nano-ZnO-treated 
group, 36.28% ± 5.37%, P , 0.05), as shown in Figure 3A. 
The performance on the number of crossing fictitious plat-
form times in rats of the nano-ZnO-treated group was not 
as good as that of the control (control, 6.67 ± 0.80 seconds; 
nano-ZnO-treated group, 2.83 ± 0.79 seconds, P , 0.05, 
Figure 3B). These results indicate that spatial reference 
memory had been reduced in the nano-ZnO-treated group.
reacquisition performance
The reacquisition phase was applied 24 hours after reten-
tion. The hidden platform was placed into the middle of 
the SW quadrant to assess an animal’s ability to reacquire 
the learned strategy. During the reacquisition phase, sig-
nificantly shorter escape latencies were obtained on the 
training trial (P , 0.05, repeated-measures ANOVA), at 
the second trial (control, 6.51 ± 1.50 seconds; nano-ZnO-
treated group, 24.56 ± 5.93 seconds, P , 0.01), the third 
trial (control, 4.86 ± 0.77 seconds; nano-ZnO-treated 
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group, 8.94 ± 1.90 seconds, P , 0.05), and the fourth trial 
(control, 1.61 ± 0.23 seconds; nano-ZnO-treated group, 
5.04 ± 1.03 seconds, P , 0.05) (Figure 4). Interestingly, at 
the same time, in temporal distribution of the quadrants, rats 
of the nano-ZnO-treated group spent a dramatically longer 
time in the SW quadrant (original location quadrant) in 
which the hidden platform had been located in the acquisition 
phase (control, 8.91% ± 2.07%; nano-ZnO-treated group, 
14.82% ± 2.85%, P , 0.05, repeated-measures ANOVA), and 
shorter time in the NE quadrant (novel location quadrant), 
in which the hidden platform was relocated in the reacqui-
sition phase (control, 61.10% ± 4.06%; nano-ZnO-treated 
group, 42.75% ± 3.59%, P , 0.01, repeated-measures 
ANOVA) than the control group (Figure 5). There was no 
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Figure 4 comparison of escape latency of reacquision phase between nano-ZnO-
treated group and control group.
Notes: Data are expressed as mean ± standard error of the mean; *P , 0.05 
compared with control group; **P , 0.01 compared with control group.
Abbreviation: nano-ZnO, zinc oxide nanoparticles.
significant difference between the two groups in the NW 
quadrant (control, 13.72% ± 1.92%; nano-ZnO-treated group, 
19.87% ± 1.97%, P . 0.05, repeated-measures ANOVA) and 
SE quadrant (control, 15.19% ± 2.36%; nano-ZnO-treated 
group, 20.05% ± 2.59%, P . 0.05, repeated-measures 
ANOVA). Therefore, reacquisition of spatial information was 
slowed down in rats of the nano-ZnO group due to much more 
time spent on exploration in the original location quadrant.
LTP and depotentiation
One of our foremost aims with this study was to investigate 
the alteration of facilitation of synaptic plasticity of the DG 
in the nano-ZnO-treated group. The data were found to be 
incompatible with the performance in the MWM. The nano-
ZnO-treated group resulted in a higher fEPSP slope but 
had worse MWM performance than the control group. As 
observed in the DG region, application of TBS resulted in an 
LTP with fEPSP slope value of 126.47% ± 0.89% (control); 
168.16% ± 0.64% (nano-ZnO-treated group) (P , 0.01, 
repeated-measures ANOVA, Figure 6A). Data showed higher 
fEPSP slope in the nano-ZnO group.
To examine whether nano-ZnO was involved in depotenti-
ation, an LFS induction protocol (600 × 2 stimuli, 20 minutes) 
was employed, and elicited significant depotentiation both in 
nano-ZnO and control group. Application of LFS resulted in 
a depotentiation with fEPSP slope value of 84.71% ± 4.95% 
(control) and 124.24% ± 6.00% (nano-ZnO-treated group, 
P , 0.01), even lower than 100.29% ± 2.00% (baseline, 
P , 0.05, repeated-measures ANOVA, Figure 6A). Since 
fEPSP slopes showed significant differences between nano-
ZnO and control groups before LFS, the differences in these 
after LFS could not be used to estimate the effect of   nano-ZnO International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
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on depotentiation. Since the significant differences existed 
between nano-ZnO and control groups before the LFS, the 
significant differences after the LFS between nano-ZnO and 
control groups can not be used to illustrate whether there 
was an effect on synaptic plasticity by nano-ZnO. Therefore,   
LTP-evoked responses of the last 20 minutes were normalized 
and used for the baseline of depotentiation (1 per minute). 
Data showed that the value of fEPSP slope was 76.9% ± 
0.52% (control) and 70.6% ± 0.23% (nano-ZnO-treated group, 
P . 0.05, repeated-measures ANOVA, Figure 6B).
Discussion
Zinc is known to adversely affect the central nervous system 
of children during fetal development. The nervous system 
seems to be extremely susceptible to the ion both in physi-
ological and pathological conditions.26 Most of the previous 
studies using animals showed behavioral and spatial learning 
effects related to zinc exposure. The present results indicate 
that zinc modulated hippocampal plasticity with bidirec-
tional effects. The lower concentrations of zinc inhibited 
depotentiation but not LTP. Such a switch-like effect of 
zinc was attributed to zinc acting via N-methyl-D-aspartate 
(NMDA) receptors. NR1/NR2A and NR1/NR2B NMDA 
receptors play complex roles in synaptic plasticity.27 Fur-
thermore, zinc modulates a wide variety of ion channels, and 
alternative ways in which zinc might act at synapses have been 
  delineated.28 In the present study, we focused on the nano-ZnO 
exposure during the postnatal brain growth spurt in rodents, 
when the nervous system might be most vulnerable.
effects of nano-ZnO on acquisition  
and retention phase in MWM
After 8-weeks treatment, nano-ZnO-treated rats began to 
exhibit cognitive deficits. The prolonged escape latencies in 
the acquisition phase indicated a slowing down of learning in 
nano-ZnO-treated rats. Importantly, a decreased percentage 
in escape latency of temporal distribution in the target (SW) 
quadrant showed a “misleading” status in nano-ZnO-treated 
rats. Because of the poor performance of spatial reference 
learning, rats had to search for the hidden platform around 
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the whole pool, which led them to spend more time in the 
non-target quadrant. Eventually, deficit learning and hinder 
orientation contributed to the prolonged escape latencies and 
resulted in a worse performance in temporal distribution of 
the target quadrant and the number of crossings of the hidden 
platform in the retention phase.
effects of nano-ZnO on reacquisition 
phase in MWM
In this phase, the hidden platform had been moved from the 
SW quadrant to the NE quadrant. Learning and memory of 
the new platform location was examined to assess the animals’ 
abilities to reacquire the learned strategy when the platform 
was moved to a new location (reversal).29 Rats in the nano-
ZnO-treated group spent more time finding the hidden plat-
form. It is worth noting that nano-ZnO-treated rats spent less 
time in the new quadrant (NE) and spent more time in the 
original quadrant (SW) than the control group in temporal 
distribution. Furthermore, the lack of significant differences 
in the NW and SE quadrants between rats of the control group 
and the nano-ZnO-treated group, in which the platform was 
never placed during the MWM, showed that rats of the nano-
ZnO-treated group took a longer period of time to find the new 
location of the hidden platform due to searching in the original 
location quadrant. This suggests a strong memory delayed 
the escape latency in the reacquisition phase, rather than a 
poor memory. A previous study reported that in wild-type 
mice, performance in the reversal MWM task was attributed 
to the capacity for cognitive flexibility; that is, the ability to 
simultaneously inhibit a previously acquired spatial navigation 
strategy and develop a new   strategy.30 In the present study, 
this capacity was weakened in rats of the nano-ZnO-treated 
group. Nano-ZnO-treated rats pertinaciously insisted on an 
inflexible strategy, suggesting that the memory associated 
with the original learning of the task stably remained in the 
nano-ZnO-treated rats. These rats lacked flexibility of learning 
and memory compared with that of control group.
effects of nano-ZnO on LTP  
and depotentiation
Underlying mechanisms of learning and memory induc-
tion and maintenance have been associated with LTP and 
depotentiation. Hence, our work focused on these effects 
of nano-ZnO.
Previous studies have shown that zinc perfusion attenu-
ated mossy fiber LTP in vitro,31 whereas Izumi et al27 claimed 
no effect of zinc in micromolar concentrations on LTP in area 
CA1 slices. Our results show the opposite: nano-ZnO signifi-
cantly enhanced LTP, then hardly impacted   depotentiation. 
However, the rapid, automatic aspect of context-specific event 
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encoding is not only dependent on intact synaptic plasticity 
but also intact function of the hippocampus.32 Although LTP 
in the hippocampus is well known to underlie learning and 
memory, LTD in the hippocampus is regarded as a crucial 
mechanism related to the acquisition of a comprehensive 
spatial map.33 The landmark encoding, conveying information 
about orientation in space, could be mediated by weakened 
spatial information in the dentate gyrus.34 Thus, based on the 
latter investigations, it is hard to say that an augmented LTP 
enhanced by nano-ZnO could improve the ability of learning 
and memory in rats.
From the perspective of neuroelectrophysiology and 
molecular biology, long-term synaptic plasticity (including 
LTP and depotentiation) is an endowed capability that regu-
lates efficiency of synaptic transmission via adjustment of the 
number of NMDA receptors and a switch of NMDA receptor 
subtypes. Such unequal effects of nano-ZnO on synaptic 
plasticity in the DG region resulted in over-amplification 
with relative and/or absolute less decay of spatial informa-
tion. This supports the interpretation of the finding that the 
spatial information reacquisition process of nano-ZnO-
treated rats was delayed in MWM. In the acquisition phase, 
acquired spatial information was excessively enhanced by 
LTP and deficiently weakened by depotentiation, resulting in 
prolonged escape latencies in the reacquisition phase. It may 
also be the reason why the nano-ZnO-treated rats spent more 
time exploring the original rather than the novel location 
quadrant to find the platform. Furthermore, it is noteworthy 
that the intensity of spatial information was weakened by 
LFS and lower than baseline in the control group, while the 
intensity was higher than that of baseline in the nano-ZnO-
treated group. This implies that the intensity of the neural 
signal was enhanced even after depotentiation in the nano-
ZnO-treated group.
We conclude that hyperactive LTP and insufficient 
depotentiation affected the process of spatial information, 
and resulted in the difficulties of finding the replaced hidden 
platform. The imbalance between LTP and depotentiation 
delayed the learning progress in the reacquisition phase in 
the nano-ZnO-treated group. Nano-ZnO-treated rats appear 
to depend on memory of the original information rather than 
using maze external clues (novel information) to guide space 
exploration when the novel spatial information did not match 
with memory. In other words, strategy flexibility was more 
rigid in the nano-ZnO-treated group than in the control.
The effects of zinc on synaptic plasticity have been 
extensively studied. Most previous studies suggested zinc 
attenuated LTP in mossy fibers,35 but another study showed 
LTP was enhanced by zinc in the hippocampal CA1 region.36 
Recently, Izumi et al found zinc induction of LTP at low 
micromolar concentrations, while attenuating it at high 
micromolar concentrations. Homeostasis of synaptic zinc is 
critical for LTP induction.37 In the present study, long-term 
exposure to nano-ZnO may have disrupted the homeostasis 
of synaptic zinc, which would then lead to hyperactive LTP 
and insufficient depotentiation.
In summary, this study demonstrated that daily intraperi-
toneal injections of nano-ZnO given over a period of 8 weeks 
to young Wistar rats affected brain function by enhancing 
LTP while barely influencing depotentiation in the DG region 
of the hippocampus. This bidirectional effect on long-term 
synaptic plasticity broke the balance between stability and 
flexibility of cognition. This can explain the phenomenon that 
nano-ZnO-treated rats displayed high LTP but a crude per-
formance of the MWM. These results are consistent with the 
hypothesis that LTP and depotentiation are not independent 
but an entity in modulating efficiency of spatial cognition.
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